Urinary, biliary and faecal excretion of rocuronium in humans

British Journal of Anaesthesia

Volumn 85, Issue 5, 2000, Pages 717-723

  Proost, J H ^a   Eriksson, L I ^b   Mirakhur, R K ^c   Roest, G ^d   Wierda, J M K H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d Organon Teknika   (Netherlands)

Author keywords

Metabolism, rocuronium; Neuromuscular block, rocuronium; Pharmacokinetics, rocuronium

Indexed keywords

CARBON DIOXIDE; DRUG METABOLITE; FENTANYL; OXYGEN; PANCURONIUM; ROCURONIUM; SODIUM DIHYDROGEN PHOSPHATE; SUXAMETHONIUM; THIOPENTAL;

ADULT; AGED; ARTICLE; BILIARY EXCRETION; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON BILE DUCT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG EXCRETION; DRUG FECES LEVEL; DRUG HALF LIFE; DRUG LIVER LEVEL; DRUG MECHANISM; DRUG METABOLISM; DRUG UPTAKE; DRUG URINE LEVEL; FEMALE; HUMAN; ILEOSTOMY; LAPAROSCOPIC SURGERY; LIVER RESECTION; MALE; MUSCLE RELAXATION; PLASMA CLEARANCE; PRIORITY JOURNAL; STOMA; T TUBE; URINARY EXCRETION;

EID: 0033759804     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/85.5.717     Document Type: Article

References (33)

1. The neuromuscular blocking effects and pharmacokinetics of Org 9426 and Org 9616 in the cat
2. Relationship between chemical structure and physicochemical properties of series of bulky organic cations and their hepatic uptake and biliary excretion rates
3. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl
4. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation
5. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org-9426) during isoflurane anaesthesia in patients with and without renal failure
6. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis
7. Pharmacokinetics and pharmacodynamics of rocuronium bromide in adult patients
8. Clinical pharmacology of rocuronium (Org 9426): Study of the time course of action, dose requirement, reversibility, and pharmacokinetics
9. The pharmacokinetics and the pharmacokinetic-dynamic relationship of rocuronium bromide
10. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease
11. The effect of isoflurane versus balanced anesthesia on rocuronium's pharmacokinetics and infusion requirement
12. Pharmacokinetics and pharmacodynamics of rocuronium at the vocal cords and the adductor pollicis in humans
13. Repeated doses of rocuronium bromide administered to cirrhotic and control patients receiving isoflurane. A clinical and pharmacokinetic study
14. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia
15. Clinical pharmacokinetics of rocuronium bromide
16. Pharmacodynamics and pharmacokinetics of rocuronium in intensive care patients
17. Pharmacokinetics of rocuronium during the three stages of liver transplantation
18. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis
19. Characterization of transport in isolated human hepatocytes. A study with the bile acid taurocholic acid, the uncharged ouabain and the organic cations vecuronium and rocuronium
20. Characterization of the uptake of rocuronium and digoxin in human hepatocytes: Carrier specificity and comparison with in vivo data
21. Hepatobiliary disposition of vecuronium bromide in man
22. Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates
23. A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics
24. A comparison of a Bayesian population method with two methods as implemented in commercially available software
25. An information criterion
26. Hepatic and biliary function
27. Pharmacodynamics and pharmacokinetics of rocuronium in intensive care patients
28. Pharmacokinetics of the long-term use of rocuronium in ICU patients with multiple organ failure (MOF)
29. Hepatobiliary elimination of cationic drugs: The role of P-glycoproteins and other ATP-dependent transporters
30. Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure
31. Structure-pharmacokinetics relationship of series of aminosteroidal neuromuscular blocking agents in the cat